Six-day clotrimazole therapy in vaginal candidosis
- 1 January 1975
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 3 (2) , 83-88
- https://doi.org/10.1185/03007997509113652
Abstract
Two hundred and two patients with symptoms, signs and mycological evidence of Candida vaginitis were entered in a single-blind trial comparing 6-day clotrimazole therapy with a control group receiving 6 days' nystatin therapy. Adequate data was collected on 69 clotrimazole and 72 nystatin treated patients for analysis. Judged by both the severity of symptoms and signs and the number of patients with negative mycological findings, 6-day clotrimazole therapy produced statistically significantly better results than obtained in the control group. When reviewed 4 weeks after starting therapy, 93% of the clotrimazole treated patinets had culturally negative results for Candida compared with 74% of the patients treated with nystatin. It is concluded that 6-day clotrimazole therapy is effective in the treatment of Candida vaginitis.Keywords
This publication has 9 references indexed in Scilit:
- Results of a Clinical Investigation of Clotrimazole (Canesten), A New Anti-Mycotic Substance, in the Therapy of Vaginal Fungal InfectionsJournal of International Medical Research, 1974
- The clinical pharmacologistPublished by Oxford University Press (OUP) ,1974
- -Blockers and Plasma Renin Activity in HypertensionBMJ, 1974
- Clinical Experience with Visken, (Prindolol) in Essential Hypertension: Its Special Comparative Action to Aldomet (Methyldopa)Journal of International Medical Research, 1973
- The therapy of Candida vaginitis and Candida vulvovaginitis with a new antimycotic substance, clotrimazoleCurrent Medical Research and Opinion, 1973
- THE USE OF PRINDOLOL (VISKEN) IN THE TREATMENT OF HYPERTENSIONThe Medical Journal of Australia, 1972
- The effect of pindolol, a beta-receptor blocking agent, in heart rate and blood-pressure during submaximal and maximal exerciseEuropean Journal of Clinical Pharmacology, 1972
- Preliminary investigations of a new beta‐adrenoceptive receptor blocking drug, LB46, in manBritish Journal of Pharmacology, 1969